Levi Garraway
Associate Professor, Medicine, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School · Ohio State University Hospital
Credentials: · · ·
History
Medical Oncology
Internal Medicine
Research
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Nature · 2012 · 6,204 citations
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Nature · 2013 · 4,258 citations
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Science · 2016 · 3,807 citations
56 papers · 5 as a fellow
48 papers
39 papers
- NW
32 papers · 1 as a fellow
- WS
30 papers
24 papers
23 papers · 4 as a fellow
18 papers
Grants
- 2015–2022
Overcoming Resistance to Targeted Therapy in Cancer
National Cancer Institute · R35
Contact PI · $1.5M · Dana-Farber Cancer Inst
- 2002–2019
DF/HCC SPORE in Prostate Cancer
National Cancer Institute · P50
Project lead · $1.2M · Dana-Farber Cancer Inst
- 2007–2019
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
National Cancer Institute · P50
Project lead · $1.2M · Dana-Farber Cancer Inst
- 2013–2019
Targetable Epigenetic and Transcriptional Mechanisms in Melanoma Thatshape the Microenvironment
National Cancer Institute · P01
Project lead · $2.9M · Massachusetts General Hospital